2025 Hospitality Neurotransmitters and mental health 
ADDitude
FEBRUARY 24, 2025
February 25, 2025 Spravato, the esketamine nasal spray approved in 2019 for use alongside oral antidepressants for treatment-resistant depression, has been approved by the U.S. Esketamine is a form of the dissociative agent ketamine , commonly used as an anesthetic; it works by targeting the neurotransmitter glutamate.
Zencare
JANUARY 22, 2025
Published on January 22, 2025 by Zencare Team. There are 298 mental health conditions currently recognized in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-TR, which is the standard reference for clinical practice among trained, licensed mental health professionals, in the US.
Expert insights. Personalized for you.
57 
Let's personalize your content